17:20 IST
BSE
Board Meeting Outcome
Trident Texofab Board Meeting Outcome
Trident Texofab's board approved the Board's Report, called the 18th AGM for September 30, 2026, and appointed a cost auditor and scrutinizer.
Trident Texofab Ltd
- Share price
- ₹20.43
- Market cap
- ₹30.64 Cr
- Revenue (annual)
- ₹118.0 Cr
- Net profit (annual)
- ₹0.70 Cr
- P/E (TTM)
- 145.5×Sector 50.4×
- Promoter holding
- 32.16%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Promoter Buying 4Other Announcement 3Financial Results 3Credit Rating 3Board Meeting Date 3Board Meeting Outcome 2Price Movement Clarification 1Management Change 1Debt & Borrowing 1Capital Structure Change 1Annual General Meeting 1
Time
2 announcements with these filters
17:24 IST
BSE
Board Meeting Outcome
Trident Texofab Board Meeting Outcome
Trident Texofab's Board approved forfeiture of 9.11 lakh lapsed warrants, forfeiting Rs.1.60 Crore. No equity capital change occurred as no shares were allotted.
- Value
- ₹1.59 Cr